Microbix Biosystems is a life science company and leading manufacturer of viral and bacterial antigens and reagents for the global diagnostics industry. Our expertise in cell biology has led to the development of new products: LumiSort, an animal reproductive product for use in livestock industries; Kinlytic, a biopharmaceutical used to treat blood clots; and VIRUSMAX, a technology used to increase influenza vaccine manufacturing yields. We are a public company listed on the Toronto Stock Exchange (TSX: “MBX”) focused on delivering value to our shareholders by growing our virology products business, as well as commercializing our new products including LumiSort and Kinlytic. In 2013 we reset the Company’s strategic priorities to focus on improving the productivity and growth potential of our diagnostics unit, while at the same time refocusing our new products to achieve near-term value driving milestones.
Share this page with your social network and connect on the topics you're passionate about – and get the conversation started.